| Net Cash Provided by (Used in) Operating Activities |
$1,117,000,000 |
USD |
31% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$404,000,000 |
USD |
10% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,081,000,000 |
USD |
-61% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
100,000 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
30 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$368,000,000 |
USD |
-37% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$2,949,000,000 |
USD |
16% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Valuation Allowance |
$32,000,000 |
USD |
0% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Gross |
$1,017,000,000 |
USD |
-27% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$850,000,000 |
USD |
2.4% |
Q2 2025 |
Q2 2025 |
| Deferred Income Tax Expense (Benefit) |
$225,000,000 |
USD |
-219% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$35,000,000 |
USD |
25% |
Q4 2024 |
FY 2024 |
| Current Income Tax Expense (Benefit) |
$201,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Unrecognized Tax Benefits |
$21,000,000 |
USD |
-12% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$985,000,000 |
USD |
-28% |
Q4 2024 |
FY 2024 |